REGISTER FOR REGULAR UPDATES
DATE AND TIME
Thu, 29 Apr. 2021, 09:30
Thu, 29 Apr. 2021, 10:30
About this webinar
Supporting the commercialisation, clinical validation and capitalisation of UK HealthTech companies in Singapore and Southeast Asia…
The growing openness to HealthTech innovations is a boon to this region’s markets, addressing immediate needs as well as long-standing problems of access and unequal standards of healthcare across Southeast Asia… Singapore stands out as an attractive base for HealthTech companies hungry for regional growth.
Dr Zubin J Daruwalla, Health Industries Leader, PwC Singapore
In this new age of personalised, patient-centric care where healthcare needs are disparate, technologies such as telehealth and remote monitoring can no longer be seen as good-to-have options. Technology is now at the forefront of health provision. The digital healthcare industry in APAC alone is estimated to be one of the fastest-growing globally, at an estimated value of US$80 billion by 2025*.
Join the Department of International Trade (DIT) UK and PwC Singapore’s Venture Hub HealthTech team to discuss:
- The HealthTech landscape of Singapore and the region
- Opportunities and challenges for HealthTech startups in Asia
- Why Singapore? Singapore as a start-up-friendly launchpad for regional expansion
- Comparison of renewed and traditional trade programmes
- Support provided by DIT UK for global expansion
Who this webinar is suitable for
This webinar is suitable for British companies working in the HealthTech sector and looking to expand operations to Singapore and Southeast Asia.
Deputy Head: Healthcare & Life Sciences
Asia Pac & Prosperity Lead | Department for International Trade
Telephone: +44 (0) 7712 234053
Register for this button on the link below.
*Source: GreenBook – HealthTech in Asia (2020)